Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

A new mouse model effectively mimics vitiligo for research and drug testing.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Fat cells help recruit healing cells and build skin structure during wound healing.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

Reducing CD8+ T cell growth can stabilize alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

New therapies are being developed that target integrin pathways to treat various diseases.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Erianin may effectively treat alopecia areata by targeting the immune system.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.